Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Pharm Res ; 37(6): 103, 2020 May 24.
Artigo em Inglês | MEDLINE | ID: mdl-32448925

RESUMO

PURPOSE: We aimed to assess intranasal (IN) epinephrine effects on cerebrospinal fluid (CSF) absorption, nasal mucosa quality, plasma epinephrine pharmacokinetics (PK), and cardiovascular changes in dogs. METHODS: CSF epinephrine concentration was measured and nasal mucosa quality was evaluated after IN epinephrine 4 mg and one or two 4 mg doses (21 min apart), respectively. Maximum plasma concentration [Cmax], time to Cmax [Tmax], area under the curve from 0 to 120 min [AUC0-120], and cardiovascular effects were evaluated after epinephrine IN (4 and 5 mg) and intramuscular (IM; 0.3 mg). Clinical observations were assessed. RESULTS: After epinephrine IN, there were no changes in CSF epinephrine or nasal mucosa. Cmax, Tmax, and AUC1-120 were similar following epinephrine IN and IM. Epinephrine IN versus IM increased plasma epinephrine at 1 min (mean ± SEM, 1.15 ± 0.48 for 4 mg IN and 1.7 ± 0.72 for 5 mg IN versus 0.47 ± 0.11 ng/mL for 0.3 mg IM). Epinephrine IN and IM produced similar heart rate and ECG results. Clinical observations included salivation and vomiting. CONCLUSIONS: Epinephrine IN did not alter CSF epinephrine or nasal tissue and had similar cardiovascular effects as epinephrine IM. Epinephrine IN rapidly increased plasma epinephrine concentration versus epinephrine IM.


Assuntos
Sistema Cardiovascular/efeitos dos fármacos , Líquido Cefalorraquidiano/metabolismo , Epinefrina/administração & dosagem , Mucosa Nasal/efeitos dos fármacos , Administração Intranasal/efeitos adversos , Anafilaxia/tratamento farmacológico , Animais , Área Sob a Curva , Cães , Avaliação Pré-Clínica de Medicamentos , Epinefrina/sangue , Epinefrina/líquido cefalorraquidiano , Epinefrina/farmacocinética , Feminino , Frequência Cardíaca/efeitos dos fármacos , Humanos , Injeções Intramusculares , Masculino , Modelos Animais , Mucosa Nasal/diagnóstico por imagem
2.
Heart Lung ; 32(6): 368-73, 2003.
Artigo em Inglês | MEDLINE | ID: mdl-14652528

RESUMO

OBJECTIVE: Exercise has been associated with improved cognitive performance among patients with coronary artery disease. Music listening has been associated with enhanced cognitive functioning among healthy adults. This study evaluated the combined influence of exercise and music listening on cognitive performance among patients in cardiac rehabilitation (CR). DESIGN AND SETTING: Using a within-subjects repeated measures design, this study was conducted in an outpatient University-based CR facility. SAMPLE: Thirty-three men and women (mean age = 62.6 +/- 10.5 years) participated in this study. METHODS: Participants completed 1 exercise session accompanied by music and a second exercise session without music. Order of conditions was assigned randomly. Before and after each exercise session, participants completed a brief assessment of depression and anxiety, and a cognitive test of verbal fluency. RESULTS: The music condition was associated with significant improvements in verbal fluency, but the no-music control condition was not associated with cognitive change. CONCLUSION: The study provides preliminary evidence of the combined benefit of exercise and music listening for cognitive performance among patients in CR.


Assuntos
Cognição/fisiologia , Doença da Artéria Coronariana/psicologia , Doença da Artéria Coronariana/reabilitação , Terapia por Exercício , Musicoterapia , Adulto , Idoso , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Avaliação de Programas e Projetos de Saúde , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA